reported the existence of an association between schizophrenia and homozygosity of a BUZZ polymorphism in the first exon of the dopamine D3 receptor (DRDS) gene. In response to this report, further studies were conducted; however, these studies yielded conflicting results. In the present study, we e
No association between schizophrenia and homozygosity at the D3 dopamine receptor gene
β Scribed by Yang, Liu ;Li, Tao ;Wiese, Claudia ;Lannfelt, Lars ;Sokoloff, Pierre ;Xu, Chong T. ;Zeng, Zhong ;Schwartz, Jean-Charles ;Liu, Xiehe ;Moises, Hans W.
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 457 KB
- Volume
- 48
- Category
- Article
- ISSN
- 0148-7299
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The dopamine D4 receptor is of major interest in schizophrenia research due to its high affinity for the atypical neuroleptic clozapine and a high degree of variability in the receptor gene (DRD4). Although several genetic linkage analyses performed on schizophrenia multiplex families from different
Dopamine D3 receptor (DRD3) was demonstrated to have important implications in schizophrenia, because it binds antipsychotic drugs and is abundant in the limbic system of the brain. Several groups attempted to find an association between a serine-to-glycine polymorphism at codon 9 of the DRD3 gene (
## A missense polymorphism (glycine to serine) in the first exon of the dopamine D3 (DRD3) gene was examined in a sib-pairs schizophrenia collection by the transmission test for linkage disequilibrium (TDT). No association due to linkage disequilibrium was detected using TDT. Additionally, no evide